News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,207 Results
Type
Article (86742)
Company Profile (703)
Press Release (763760)
Multimedia
Podcasts (139)
Webinars (18)
Section
Business (232776)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91062)
Employer Resources (198)
FDA (18159)
Job Trends (17354)
News (396712)
Policy (39798)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56937)
ALS (112)
Alzheimer's disease (1536)
Antibody-drug conjugate (ADC) (186)
Approvals (18108)
Artificial intelligence (376)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (377)
Cancer (2925)
Cardiovascular disease (235)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (36)
Cell therapy (550)
Cervical cancer (24)
Clinical research (74036)
Collaboration (1049)
Company closure (3)
Compensation (655)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (319)
Cystic fibrosis (117)
Data (2884)
Decentralized trials (2)
Denatured (48)
Depression (66)
Diabetes (336)
Diagnostics (6964)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (148)
Drug shortages (35)
Duchenne muscular dystrophy (125)
Earnings (97420)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131272)
Executive appointments (890)
FDA (19774)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (960)
Gene editing (142)
Generative AI (37)
Gene therapy (417)
GLP-1 (903)
Government (5230)
Grass and pollen (6)
Guidances (180)
Healthcare (20911)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (38)
Infectious disease (3071)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (119)
Interviews (813)
IPO (17889)
IRA (54)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (414)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (414)
MASH (92)
Medical device (14694)
Medtech (14699)
Mergers & acquisitions (22535)
Metabolic disorders (887)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2250)
NextGen: Class of 2025 (7687)
Non-profit (5088)
Now hiring (47)
Obesity (467)
Opinion (286)
Ovarian cancer (97)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (191)
Partnered (25)
Patents (301)
Patient recruitment (144)
Peanut (54)
People (65609)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22863)
Phase II (32150)
Phase III (24201)
Pipeline (1609)
Policy (223)
Postmarket research (3552)
Preclinical (10321)
Press Release (72)
Prostate cancer (140)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (495)
Real estate (7398)
Recruiting (75)
Regulatory (27017)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (164)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (89)
Vaccines (881)
Venture capital (52)
Weight loss (317)
Women's health (48)
Worklife (20)
Date
Today (128)
Last 7 days (580)
Last 30 days (2781)
Last 365 days (34294)
2025 (16746)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50429)
Australia (8865)
California (7494)
Canada (2309)
China (686)
Colorado (320)
Connecticut (338)
Delaware (193)
Europe (115700)
Florida (1106)
Georgia (255)
Hawaii (1)
Idaho (65)
Illinois (713)
India (32)
Indiana (373)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1074)
Massachusetts (5733)
Michigan (269)
Minnesota (468)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2087)
New Mexico (31)
New York (2107)
North Carolina (1214)
North Dakota (10)
Northern California (3230)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1604)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2761)
Tennessee (123)
Texas (1130)
United States (28322)
Utah (222)
Virginia (201)
Washington D.C. (80)
Washington State (661)
West Virginia (4)
Wisconsin (82)
There are 851,207 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans
June 19, 2025
·
4 min read
Press Releases
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
June 19, 2025
·
7 min read
Press Releases
HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025
June 19, 2025
·
1 min read
Press Releases
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
June 19, 2025
·
8 min read
Press Releases
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
June 19, 2025
·
12 min read
Press Releases
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
June 19, 2025
·
7 min read
Press Releases
Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors
June 19, 2025
·
6 min read
Press Releases
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
June 19, 2025
·
2 min read
Press Releases
F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim
June 19, 2025
·
9 min read
Press Releases
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China
June 19, 2025
·
2 min read
1 of 85,121
Next
